James J. Devlin
Comptroller/Controller/Auditor at CrossAmerica GP LLC
Profile
James J.
Devlin's current job is as a Controller at CrossAmerica GP LLC.
His former jobs include being a Vice President & Controller at Impax Laboratories LLC from 2005 to 2011, and serving as the Chief Accounting Officer & Controller at CrossAmerica Partners LP.
He has an undergraduate degree from LaSalle University and an MBA from St. Joseph's University.
James J. Devlin active positions
| Companies | Position | Start |
|---|---|---|
CrossAmerica GP LLC
 CrossAmerica GP LLC Wholesale DistributorsDistribution Services CrossAmerica GP LLC provides petroleum products. The company is headquartered in Dover, DE. | Comptroller/Controller/Auditor | 2012-06-30 |
Former positions of James J. Devlin
| Companies | Position | End |
|---|---|---|
| CROSSAMERICA PARTNERS LP | Comptroller/Controller/Auditor | 2013-06-06 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Comptroller/Controller/Auditor | 2011-11-30 |
Training of James J. Devlin
| St. Joseph's University | Masters Business Admin |
| LaSalle University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CROSSAMERICA PARTNERS LP | Distribution Services |
| Private companies | 2 |
|---|---|
CrossAmerica GP LLC
CrossAmerica GP LLC Wholesale DistributorsDistribution Services CrossAmerica GP LLC provides petroleum products. The company is headquartered in Dover, DE. | Distribution Services |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- James J. Devlin
